Dr. Ifeoluwa Adabonyan, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 12500 Willowbrook Rd, Emergency Department, Cumberland, MD 21502 Phone: 240-964-1200 |
Dr. William Alan May, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 900 Seton Dr, Cumberland, MD 21502 Phone: 301-723-5161 |
Dr. Sukhjit S Sidhu, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Memorial Ave, Cumberland, MD 21502 Phone: 866-668-6303 |
Mr. Sanjeeb Sudarshan Bhandari, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 667-218-8253 Fax: 240-964-7000 |
Jeffrey Davis, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 Memorial Ave, Cumberland, MD 21502 Phone: 301-723-4070 |
Dr. Mark Howell Koury, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 Memorial Ave, Emergency Dept., Cumberland, MD 21502 Phone: 301-723-4100 |
Michael Weddle, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 Memorial Ave, Cumberland, MD 21502 Phone: 301-723-4070 |
Dr. Ronna Mathias Monseau, M.D/ Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14302 Barton Blvd Sw, Cumberland, MD 21502 Phone: 301-729-3278 Fax: 301-729-8702 |
Dr. Matthew Roger Black, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 124-096-4120 |
Eric S Hansen, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-7000 |
Dr. Nannette Mccullough, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 600 Memorial Ave, Cumberland, MD 21502 Phone: 310-723-4100 |
News Archive
Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).
For cancer patients, who have an increased risk of developing venous thromboembolism (VTE) due to a hyperactive blood coagulation system, there is now an enhanced risk model to predict their chance of developing blood clots, according to a recent study published today in Blood, the journal of the American Society of Hematology.
Advanced stage cancer diagnoses declined following health insurance expansion in Massachusetts, likely due to increased access to screening and diagnostic services that identified cancers earlier, according to new research led by health economists at the University of Pittsburgh Graduate School of Public Health.
A new magnetic pill system developed by Brown University researchers could solve the problem by safely holding a pill in place in the intestine wherever it needs to be.
› Verified 4 days ago